A Study of Ketamine in Patients With Treatment-resistant Depression

Clinical trial NCT01627782 · COMPLETED

Trial details

NCT number: NCT01627782
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2012-08-06
Primary completion: 2013-09-12
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.